Life isn’t always sunshine and rainbows. While some days feel like a breeze, other days are chaos. That’s where a little positivity makes all the difference. We’ve curated more than 85 positive ...

Biogen and Eisai have hit another bump in their quest to win European regulatory approval of their Alzheimer's drug Leqembi ... the panel finally adopted a positive opinion in November.

Alzheimer’s disease is the most common form of dementia. Anjali Patel, DO, a cognitive neurologist at Atlantic Health System, shares more. Alzheimer’s disease is a progressive neurological disorder ...

Best Mahatma Gandhi Quotes: Mahatma Gandhi, the Father of the Nation, is one of the most revered leaders in history. He was a lawyer, politician, social activist, and writer who dedicated his ...

Alzheimer’s can cause distressing behaviors for both the person and caregivers. While not everyone with the condition will become aggressive, it’s important to know how to manage these ...

Are massage or touch therapies beneficial to individuals with Alzheimer’s disease? Italian Renaissance artist Michelangelo once said, “To touch is to give life.” Scientists and studies have ...

Garden designer Marina Randall shares her fascination and expertise for creating dementia-friendly spaces in nature. Garden designer Marina Randall shares her fascination and expertise for creating ...

Here are a few of the top charities tackling Alzheimer’s disease. These organizations fund research, raise awareness, educate, and provide comfort to those living with and caring for those with ...

So, if you’re a fan of sports dramas or inspirational movies based on a true story, “You Gotta Believe” could be your next choice now that it’s available on Netflix. Here’s everything to ...

“We are very excited by these positive Phase 1 data, which further support continued development of VG-3927 as a potential next-generation therapy for AD,” said Ivana Magovčević ...

Vigil Neuroscience has reported early clinical data on its Alzheimer’s disease candidate, positioning the biotech to advance its small molecule in the footsteps of AbbVie and Alector’s failed ...